Biomedical & Medtech Manufacturing
MSD (Merck & Co)
UNCLAIMED RECORD · Claim it →A 72-acre multi-product Tuas hub whose chemical plant has historically produced small-molecule APIs (including etoricoxib and simvastatin), with a US$500 million programme adding sterile fill-finish and secondary packaging for biologic products — KEYTRUDA (pembrolizumab) vials and GARDASIL 9 syringes. Singapore headcount exceeds 1,800.
Capabilities
Sources
CLAIM THIS RECORD
Is this your company?
MSD (Merck & Co) is on the Singapore Industry Index as a reference record, compiled from public sources. Claiming it is free — correct the facts, add capabilities and certifications, appear on more pages, and receive enquiries routed directly to you.
Spotted an error? Claiming is the fastest way to fix it — or write to us via Contact.